Advertisement

ADHIKHOLA LAGHUBITTA BITTIYA SANSTHA LIMITED (AKBSL)

Microfinance · Rs. 919.00 -34.20 (-3.59%) as of Mar 13, 2023

Price — last 6 months

Full chart →
Open
953.20
High / Low
958.80 / 912.00
Prev. close
953.20
Volume
2,001
52-week high
52-week low
Market cap
Shares outstanding

MASTER score

Mechanical 0–100 technical ranking. Methodology →

Promoter holding
Public holding

Stock performance

1-week change
-0.54%
1-month change
-24.30%
3-month change
-12.80%
6-month change
-12.80%
YTD change
-23.18%
1-year change
+205.74%
1-month high
1,200.00
1-month low
847.00
From 52-week high
From 52-week low
180-day avg price
1,173.96
360-day avg price
1,018.98
Avg volume (1w)
2,271
Avg volume (1m)
1,921
Avg volume (6m)
4,239
Avg volume (12m)
4,396
Daily volatility (1m)
4.48%
Beta vs NEPSE (1y)

Valuation

EPS (annualized)
EPS (TTM)
P/E
P/B
Book value / share
ROE
ROA
Net profit margin
Graham number
Dividend yield
Dividend

P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →

Key indicators vs Microfinance

EPS (Rs.)
N/A
min 7.01avg 33.38max 110.66
P/E
N/A
min 14.46avg 37.89max 106.67
P/B
N/A
min 2.27avg 5.42max 13.86
Networth / Share (Rs.)
N/A
min 103.10avg 198.69max 362.38
ROE (%)
N/A
min 5.65avg 16.46max 35.93

Technical indicators

RSI (14)35.66Neutral
MACD-63.34Bearish
EMA 5943.08Bearish
EMA 201,025.32Bearish
EMA 180
SMA 501,173.96Bearish
SMA 200
Pivot levels (classic)
S3
854.27
S2
883.13
S1
901.07
PP
929.93
R1
947.87
R2
976.73
R3
994.67

Key financials — last 8 quarters

amounts in Rs · per-share in Rs

No filed statements found.

More Microfinance stocks

AKBSL — frequently asked questions

What is ADHIKHOLA LAGHUBITTA BITTIYA SANSTHA LIMITED's share price?

Rs. 919.00 as of Mar 13, 2023, the latest NEPSE trading session (-3.59% on the day).

What dividend did AKBSL pay?

No dividend on record for the most recent fiscal year in our data.

Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.